KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Notes Payables: 2011

Historic Notes Payables for Dynavax Technologies (DVAX) over the last 1 years, with Dec 2011 value amounting to $12.8 million.

  • Dynavax Technologies' Notes Payables was N/A to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year change of. This contributed to the annual value of $12.8 million for FY2011, which is N/A change from last year.
  • Per Dynavax Technologies' latest filing, its Notes Payables stood at $12.8 million for FY2011.
  • In the past 5 years, Dynavax Technologies' Notes Payables registered a high of $12.8 million during FY2011, and its lowest value of $12.8 million during FY2011.
  • Its 1-year average for Notes Payables is $12.8 million, with a median of $12.8 million in 2011.